Compare KGEI & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KGEI | MBOT |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.1M | 135.7M |
| IPO Year | N/A | N/A |
| Metric | KGEI | MBOT |
|---|---|---|
| Price | $3.96 | $1.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $11.00 | $8.75 |
| AVG Volume (30 Days) | 98.5K | ★ 1.1M |
| Earning Date | 03-24-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.99 | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $60,121,000.00 | N/A |
| Revenue This Year | $2.54 | N/A |
| Revenue Next Year | $12.86 | $3,119.61 |
| P/E Ratio | $7.94 | ★ N/A |
| Revenue Growth | ★ 10.00 | N/A |
| 52 Week Low | $3.35 | $1.25 |
| 52 Week High | $9.89 | $4.67 |
| Indicator | KGEI | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 31.84 |
| Support Level | $3.82 | $1.96 |
| Resistance Level | $4.03 | $2.21 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 74.58 | 7.84 |
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.